Central AsianResearch Index

<b>СРАВНИТЕЛЬНЫЙ АНАЛИЗ ЭФФЕКТИВНОСТИ КОММЕРЧЕСКИХ ВАКЦИН ПРОТИВ ИНФЕКЦИОННОЙ БУРСАЛЬНОЙ БОЛЕЗНИ, ИСПОЛЬЗУЕМЫХ НА ТЕРРИТОРИИ КАЗАХСТАНА.</b>

Infectious bursal disease (IBD) remains a major challenge in commercial poultry production, associated with immunosuppression and economic losses. In Kazakhstan, vaccination efficacy is largely influenced by maternally derived antibodies (MDA) and the formation of an “immunological window.” This study aimed to compare the immune response and safety of an HVT-IBD vector vaccine (strain vHVT013-69) and a live attenuated vaccine (strain Winterfield 2512) in broiler chickens. In the live vaccine group, antibody titers decreased to 1565 (95% CI 1292–1838) on day 14 and increased to 8503 (95% CI 8060–8946) by day 35, with variable and MDA-dependent response; one mortality case and bursal lesions (b/B 0.80 ± 0.05) were observed. In the HVT-IBD group, titers declined without critical drops (6024; 95% CI 4523–7525) and increased to 9535 (95% CI 8146–10924); no mortality occurred, and bursal structure was preserved (b/B 1.34 ± 0.06). In the control group, post-challenge titers reached 11,388 (95% CI 10734–12041) with 40% mortality. These findings indicate that high antibody titers do not necessarily reflect protection. The HVT-IBD vector vaccine provides a more stable and safer immune response and is preferable under variable MDA conditions.

Сведения

Опубликовано
2026 · Т. 82, № 3, С. 210-223
Язык
Русский
ISSN
3134-8114 · 3134-8122
Издатель
West Kazakhstan Agrarian Technical University named after Zhangir Khan